Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only
Get Premium
ATRC AtriCure Inc
- Stocks
- Healthcare
- NASDAQ: ATRC
Price (delayed)
$30.99
Market cap
$1.53B
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.81
Enterprise value
$1.51B
AtriCure, Inc. provides innovative technologies for the treatment of Afib and related conditions. Afib affects more than 33 million people worldwide. Electrophysiologists and cardiothoracic surgeons around the globe use AtriCure
Highlights
ATRC's revenue is up by 16% year-on-year and by 3.2% since the previous quarter
AtriCure's EPS has increased by 15% from the previous quarter
ATRC's net income is up by 15% QoQ but it is down by 2.5% YoY
The debt has grown by 2.7% YoY
Key stats
What are the main financial stats of ATRC
Market
Valuations
Earnings
Shares outstanding
49.5M
Market cap
$1.53B
Enterprise value
$1.51B
Price to earnings (P/E)
N/A
Price to book (P/B)
3.33
Price to sales (P/S)
3.06
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
3.15
Revenue
$480.08M
Gross profit
$358.88M
Operating income
-$35.05M
Net income
-$38.18M
EBIT
-$30.95M
EBITDA
-$11.59M
Free cash flow
$11.35M
Per share
Balance sheet
Liquidity
EPS
-$0.81
EPS diluted
-$0.81
Free cash flow per share
$0.24
Book value per share
$9.3
Revenue per share
$10.13
TBVPS
$6.38
Total assets
$591.63M
Total liabilities
$137.01M
Debt
$77.41M
Equity
$454.62M
Working capital
$190.26M
Debt to equity
0.17
Current ratio
4.11
Quick ratio
2.67
Net debt/EBITDA
1.94
Margins
Efficiency
Dividend
EBITDA margin
-2.4%
Gross margin
74.8%
Net margin
-8%
Operating margin
-7.3%
Return on assets
-6.3%
Return on equity
-8.3%
Return on invested capital
-15.1%
Return on capital employed
-5.8%
Return on sales
-6.4%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
ATRC stock price
How has the AtriCure stock price performed over time
Intraday
-0.61%
1 week
3.23%
1 month
-6.37%
1 year
40.86%
YTD
1.41%
QTD
-3.94%
Financial performance
How have AtriCure's revenue and profit performed over time
Revenue
$480.08M
Gross profit
$358.88M
Operating income
-$35.05M
Net income
-$38.18M
Gross margin
74.8%
Net margin
-8%
The net margin has grown by 17% from the previous quarter and by 11% YoY
ATRC's revenue is up by 16% year-on-year and by 3.2% since the previous quarter
The operating margin has grown by 15% since the previous quarter and by 5% year-on-year
The company's gross profit rose by 15% YoY and by 3.3% QoQ
Price vs fundamentals
How does ATRC's price correlate with its fundamentals
Growth
What is AtriCure's growth rate over time
Valuation
What is AtriCure stock price valuation
P/E
N/A
P/B
3.33
P/S
3.06
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
3.15
AtriCure's EPS has increased by 15% from the previous quarter
ATRC's price to book (P/B) is 31% lower than its 5-year quarterly average of 4.8 but 11% higher than its last 4 quarters average of 3.0
ATRC's P/S is 58% below its 5-year quarterly average of 7.3 but 6% above its last 4 quarters average of 2.9
ATRC's revenue is up by 16% year-on-year and by 3.2% since the previous quarter
Efficiency
How efficient is AtriCure business performance
AtriCure's ROS has increased by 20% from the previous quarter and by 10% YoY
The company's return on invested capital fell by 17% YoY but it rose by 14% QoQ
AtriCure's return on assets has increased by 15% QoQ
The ROE has grown by 14% from the previous quarter but it has contracted by 2.5% YoY
Dividends
What is ATRC's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for ATRC.
Financial health
How did AtriCure financials performed over time
The current ratio is up by 13% since the previous quarter and by 2.8% year-on-year
The total liabilities has declined by 8% since the previous quarter
The debt is 83% less than the equity
The debt has grown by 2.7% YoY
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.